Evaluation of Functional Improvement After Spa Therapy in Fontcaude Center (FONTCAUDE)
Primary Purpose
Knee Osteoarthritis
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Spa Treatment
Sponsored by
About this trial
This is an interventional other trial for Knee Osteoarthritis
Eligibility Criteria
Inclusion criteria:
- Patient aged 40 to 75 years with radiologic and gonarthrosis radiologic et painful gonarthrosis, unilateral ou bilateral, whatever is the radiographic stage
- Patient presenting a EVA ≥3 with a corresponding radiology at least of 1year
- Patient affiliated with a social security system
Exclusion criteria:
- Realization of a water cure in the last 6 months
- Infiltration of the knee of less than 3 months
- Impossibility to sign the informed consent or which for reasons geographical, social or psychological could not be regularly followed,
- Person major placed under guardianship or trusteeship,
- Private person of freedom by court or administrative order, nobody being the object of a legal protective measure,
- Patient already included in an interventional clinical protocol,
- Pregnant women
Contraindication in the water cure:
- Severe change of the general state or debilitating afflictions
- Acute affections and pushed acute(sharp) of the chronic affections
- Grave cardiac insufficiency, unstable arterial high blood pressure
- Severe renal or hepatic insufficiency
- Not healed cutaneous hurts
- Contagious or evolutionary diseases
- Evolutionary Cancers
- Current immunomodulator or immunosupressor Treatment, waves of inflammation.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Thermal care
Standard Care
Arm Description
Spa Treatment realised daily 6 days a week during 18 days
Usual care
Outcomes
Primary Outcome Measures
Achievement of minimal clinically important improvement (MCII) at 6 months
The main endpoint is the number of patients achieving minimal clinically important improvement (MCII) at 6 months, defined as ≥19.9 mm on the visual analogue pain scale and/or ≥9.1 points in a normalised Western Ontario and McMaster Universities osteoart
Secondary Outcome Measures
Achievement of minimal clinically important improvement (MCII) at 3 months
The second outcome measure is the number of patients achieving minimal clinically important improvement (MCII) at 3 months, defi ned as ≥19.9 mm on the visual analogue pain scale and/or ≥9.1 points in a normalised Western Ontario and McMaster Universities osteoarthritis index function score, and also the safety.
Full Information
NCT ID
NCT03289078
First Posted
September 18, 2017
Last Updated
May 11, 2021
Sponsor
University Hospital, Montpellier
Collaborators
FONTCAUDE's Vichy SPA center, Juvignac
1. Study Identification
Unique Protocol Identification Number
NCT03289078
Brief Title
Evaluation of Functional Improvement After Spa Therapy in Fontcaude Center
Acronym
FONTCAUDE
Official Title
Evaluation of Functional Improvement After Spa Therapy in Fontcaude Center, for Knee Osteoarthritis
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Withdrawn
Why Stopped
No financing
Study Start Date
October 2017 (Anticipated)
Primary Completion Date
April 2020 (Anticipated)
Study Completion Date
October 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier
Collaborators
FONTCAUDE's Vichy SPA center, Juvignac
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Evaluation of functional improvement after spa therapy in Fontcaude center, for knee osteoarthritis Background. Knee osteoarthritis is the first indication of spa therapy in rheumatology. This therapeutic represents a non pharmacological treatment and is recommended by OARSI.
In order to obtain agreement for spa therapy, the center Fontcaude, needs to show clinical improvement for patients, as demonstrated in the Thermarthrose study. This center is near Montpellier and could improve patients localised in this area.
Detailed Description
Methods: randomised prospective clinical trial of patients with knee osteoarthritis.
The spa therapy group received 18 days of therapy over 3 weeks. Patients in the control group received 18 days of therapy over 3 weeks after the 6-month follow-up visit.
Follow-up was at 3 and 6 months, by a visit to the examination.
The hypothesis of our study is to demonstrate clinical improvement at six months. The main endpoint is the number of patients achieving minimal clinically important improvement (MCII) at 6 months, defi ned as ≥19.9 mm on the visual analogue pain scale and/or ≥9.1 points in a normalised Western Ontario and McMaster Universities osteoarthritis index function score.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Thermal care
Arm Type
Experimental
Arm Description
Spa Treatment realised daily 6 days a week during 18 days
Arm Title
Standard Care
Arm Type
No Intervention
Arm Description
Usual care
Intervention Type
Other
Intervention Name(s)
Spa Treatment
Intervention Description
The spa treatments will be realised daily 6 days a week and during 18 days. The care will be provided is : Swimming pool of mobilization by physical therapist (20 minutes daily, Cataplasms (10 minutes daily), Shower in the jet (10 minutes daily), Shower under affusion (10 minutes daily)
Primary Outcome Measure Information:
Title
Achievement of minimal clinically important improvement (MCII) at 6 months
Description
The main endpoint is the number of patients achieving minimal clinically important improvement (MCII) at 6 months, defined as ≥19.9 mm on the visual analogue pain scale and/or ≥9.1 points in a normalised Western Ontario and McMaster Universities osteoart
Time Frame
30 months
Secondary Outcome Measure Information:
Title
Achievement of minimal clinically important improvement (MCII) at 3 months
Description
The second outcome measure is the number of patients achieving minimal clinically important improvement (MCII) at 3 months, defi ned as ≥19.9 mm on the visual analogue pain scale and/or ≥9.1 points in a normalised Western Ontario and McMaster Universities osteoarthritis index function score, and also the safety.
Time Frame
30 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
Patient aged 40 to 75 years with radiologic and gonarthrosis radiologic et painful gonarthrosis, unilateral ou bilateral, whatever is the radiographic stage
Patient presenting a EVA ≥3 with a corresponding radiology at least of 1year
Patient affiliated with a social security system
Exclusion criteria:
Realization of a water cure in the last 6 months
Infiltration of the knee of less than 3 months
Impossibility to sign the informed consent or which for reasons geographical, social or psychological could not be regularly followed,
Person major placed under guardianship or trusteeship,
Private person of freedom by court or administrative order, nobody being the object of a legal protective measure,
Patient already included in an interventional clinical protocol,
Pregnant women
Contraindication in the water cure:
Severe change of the general state or debilitating afflictions
Acute affections and pushed acute(sharp) of the chronic affections
Grave cardiac insufficiency, unstable arterial high blood pressure
Severe renal or hepatic insufficiency
Not healed cutaneous hurts
Contagious or evolutionary diseases
Evolutionary Cancers
Current immunomodulator or immunosupressor Treatment, waves of inflammation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Isabel TAVARES, PH
Organizational Affiliation
CHU de Montpellier
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Evaluation of Functional Improvement After Spa Therapy in Fontcaude Center
We'll reach out to this number within 24 hrs